LIII: Are the claims by or on behalf of a Russian entity? [430]-[433]
LIII: Are the claims by or on behalf of a Russian entity? [430]-[433]
In the light of the Assignment, a further question also arises in relation to Article 11(1) of Regulation 833. It provides that claims in connection with any contract which has been affected by Regulation 833 shall not be satisfied, if they are made by any persons within categories (a), (b) or (c), as set out.
The claims under the Bonds were originally made by EuroChem NW2, which is a Russian entity. I understand the Claimants’ case to be that the claims are now made by EuroChem AG. They rely on clause 2(b) of the Assignment, which provides that they “have the right to seek enforcement with respect to the Claimed Amounts and pursue all claims and demands”.
However, the correct analysis is that set out in ‘Guide to ICC Uniform Rules for Demand Guarantees URDG 758’ at paragraphs 33.20-21, which I have set out in Section XXV above. As a mere assignment of proceeds, the Assignment did not make EuroChem AG a party to the Bonds or entitled to make a demand in its own name. Nor did it in fact purport to do so. It has at all times relied on the demands made by EuroChem NW2. At most, the assignment may have conferred beneficial rights, so that EuroChem AG became entitled (if necessary) to require EuroChem NW2 to allow EuroChem AG to use its name for the purpose of pursuing claims under the Bonds, with a view to recovering the proceeds.
As that work notes at paragraph 33.21, EuroChem AG acquired its rights under the Assignment “…subject to any claims and defences that would have been available against the assignor”. In principle, this includes any defence arising from Regulation 833.
- Heading
- PART A: INTRODUCTION AND PARTIES [1]-[22]
- II: The Claimants [11]-[17]
- III: The Banks and Tecnimont [18]-[20]
- IV: The new Kingisepp plant [21]-[22]
- PART B: THE BONDS AND EUROCHEM NW2’S DEMANDS [23]-[45]
- VI: Designation under Regulation 269 [29]-[33]
- VII: Termination of the Contracts [34]-[37]
- VIII: EuroChem NW2’s demands on the Bonds [38]-[40]
- IX: Rejection of the demands [41]-[45]
- PART C: THE ISSUES AND THE WITNESSES [46]-[98]
- XI: The Claimants’ EuroChem AG witnesses [59]-[66]
- Mr Valters and Mr Solzhenitsyn
- Mr Hechler
- Mr Collishe
- Ms Basyrova
- XII: The Claimants’ EuroChem NW2 witness [67]-[73]
- XIII: The Claimants’ Trust witnesses [74]-[94]
- Mr Fokin
- Mr Noble
- XIV: The Banks’ witnesses [95]-[98]
- PART D: THE FACTS RE OWNERSHIP AND CONTROL [99]-[211]
- The Trusts above EuroChem AG
- The structure from EuroChem AG downwards
- XVI: The ownership structure after sanctions [110]-[123]
- Changes at the level of EuroChem AG
- Changes in directorships
- XVII: Other group structural changes [124]-[144]
- The “Future of EuroChem” memorandum
- The transfers to MCC EuroChem
- The UAE trading cluster
- Changes within EuroChem AG and the EU subsidiaries
- XVIII: Mr Melnichenko’s involvement before March 2022 [145]-[151]
- XIX: The Claimants’ first pleading point [152]-[154]
- XX: The date of the Deed of Retirement [155]-[165]
- XXI: The role of Mrs Melnichenko [166]-[175]
- XXII: Mr Melnichenko’s involvement after March 2022 (1) [176]-[187]
- XXIII: The Claimants’ second pleading point [188]-[197]
- XXIV: Mr Melnichenko’s involvement after March 2022 (2) [198]-[204]
- XXV: The Assignment [205]-[211]
- PART E: REGULATION 269 [212]-[305]
- XXVII: The supplementary EU materials [220]-[225]
- XXVIII: Decisions of the CJEU [226]-[229]
- XXIX: How to interpret Regulation 269 [230]-[240]
- XXX: Article 2(1) [241]-[248]
- XXXI: Article 2(2) [249]-[259]
- XXXII: “Ownership” [260]-[278]
- XXXIII: The Claimants’ third pleading point [279]-[282]
- XXXIV: The MP Bank v Pugachev point [283]-[293]
- XXXV: “Control” [294]-[305]
- PART F: THE NCAS [306]-[347]
- XXXVII: Firewalls and the NCAs [312]-[313]
- XXXVIII: The French NCA: the DGT [314]-[326]
- XXXIX: The Italian NCA: the CSF [327]-[332]
- XL: The Swiss NCA: the SECO [333]-[337]
- XLI: The Cypriot NCA: the SEOK [338]-[341]
- XLII: The Dutch NCA: the BTI [342]-[347]
- PART G: APPLYING REGULATION 269 [348]-[411]
- XLIV: Inferences [360]-[369]
- XLV: Article 2(1) and the Bonds [370]-[378]
- XLVI: The LIA v Maud point [379]-[399]
- XLVII: Article 2(1) and the Assignment [400]
- XLVIII: Article 2(2) and payment to EuroChem NW2 [401]-[403]
- XLIX: Article 2(2) and payment to EuroChem AG [404]-[408]
- L: The pending applications to the DGT and the CSF [409]-[411]
- PART H: REGULATION 833 [412]-[473]
- LII: Are the claims “in connection with” the Contracts? [416]-[429]
- LIII: Are the claims by or on behalf of a Russian entity? [430]-[433]
- LIV: Conclusion on Regulation 833 [434]-[435]
- PART I: THE RULE IN RALLI BROTHERS [436]-[473]
- LVI: The rule in Ralli Brothers [438]-[440]
- LVII: The place of performance under the Bonds [441]-[461]
- LVIII: Licence applications and Article 7 [462]-[465]
- LIX: Public policy [466]-[470]
- LX: Implied term [471]-[472]
- LXI: Conclusion on the rule in Ralli Brothers [473]
- PART J: OTHER ARGUMENTS [474]-[494]
- LXIII: The Bonds’ expiry dates [476]-[478]
- LXIV: Validity of the Assignment [479]-[482]
- LXV: The Assignment and Article 9 [483]-[486]
- LXVI: The sanctioned Russian banks [487]-[491]
- LXVII: ING’s Part 20 claim against Tecnimont [492]-[494]
- Conclusions
![CL-2022-000456 - [2025] EWHC 1938 (Comm)](https://backend.juristeca.com/files/emisores/logo_WAai98v.png)